Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide and ATG Conditioning for BMT in Severe Aplastic Anemia
NCT00343785Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Feb 2006
- Primary completion
- May 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, antithymocyte globulin rabbit in aplastic anemia, sponsored by Fred Hutchinson Cancer Center. Started Feb 2006; status: completed.
02
Drugs
cyclophosphamideantithymocyte globulin rabbit
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT00343785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343785.